Dr. Sahil Khanna is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. He completed Medical School at the All India Institute of Medical Sciences, New Delhi; Post Doctoral Research at University of California San Diego, CA; Residency in Internal Medicine and Fellowship in Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN before joining the Faculty. He also completed a Masters in Clinical and Translational Sciences at Mayo Clinic. His interests include Epidemiology, Outcomes and Emerging Therapeutics for Clostridioides difficile, an arena in which he has had over 150 publications and numerous presentations. He is directing the Consultative Gastroenterology Interest group, C. difficile Clinic, Fecal Microbiota Transplantation program and C. difficile-related clinical trials at Mayo Clinic, Rochester, MN. He has won numerous awards including the Miles and Shirley Fiterman Award, the Mayo Brothers Distinguished Fellowship Award, and the Donald C. Balfour Mayo Clinic Alumni Association Research Award, amongst others.